AstraZeneca Covid 19 vaccine - Angel Broking

Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd

"AstraZeneca Covid 19 vaccine put on HOLD - A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford a frontrunner in the race for a covid-19 vaccine. Vaccine is in phase 3 trials and Halted global trails of the vaccine to investigate an inflammatory syndrome called transverse myelitis in one volunteer. Standard review triggered a pause to vaccination to allow review of safety data. This is negative news for AstraZeneca and for global markets."

Shares of ASTRAZENECA PHARMA INDIA LTD. was last trading in BSE at Rs.4214.8 as compared to the previous close of Rs. 4588.85. The total number of shares traded during the day was 81778 in over 17536 trades.

The stock hit an intraday high of Rs. 4970 and intraday low of 4105. The net turnover during the day was Rs. 363295481.

Source : Equity Bulls

Keywords